A machine learning model generated by a team from the European Society for Blood and Marrow Transplantation (EBMT) outperformed standard statistical models in identifying and stratifying transplant risk for patients with myelofibrosis, according to new research published in Blood.
Open-access machine learning model enhances transplant risk assessment in myelofibrosis patients
